 | • レポートコード：MRC2-11QY13567 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は急性腎不全治療薬のグローバル市場について調査・分析したレポートです。種類別（重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他）市場規模、用途別（病院、診療所、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性腎不全治療薬の競争状況、市場シェア ・世界の急性腎不全治療薬市場：種類別市場規模 2015年-2020年（重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他） ・世界の急性腎不全治療薬市場：種類別市場規模予測 2021年-2026年（重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他） ・世界の急性腎不全治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、外来手術センター） ・世界の急性腎不全治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、外来手術センター） ・北米の急性腎不全治療薬市場分析：米国、カナダ ・ヨーロッパの急性腎不全治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性腎不全治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性腎不全治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性腎不全治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、Teva Pharmaceutical、Pfizer、Novartis、Eisai Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.
Acute renal failure associated with mortality, organ dysfunctions, and development of chronic kidney diseases. It also has long term and short term issues in functional status and leads to increased healthcare expenditure. The incidence of acute renal failure is high and it most common in elderly, diabetic and obese. Etiology is also high and may be secondary to infections such as dengue, malaria, and leptospirosis. The proportion of patients receiving treatment for acute renal failure depends on the economies of the countries. Renal failure is more common in low-middle income countries followed by high-income countries. Because increasing burden of acute renal failure, professional organizations and societies are disseminating information effectively to increase awareness. American Society of Nephrology and International society of nephrology are professional organization involved in fostering education and research. Acute renal failure is common globally and imposes high health care burden. All these factors act as drivers in the robust growth of acute renal failure therapeutic.
Market Analysis and Insights: Global Acute Renal Failure Therapeutics Market
The global Acute Renal Failure Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Acute Renal Failure Therapeutics Scope and Market Size
Acute Renal Failure Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Renal Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Baxter
Teva Pharmaceutical
Pfizer
Novartis
Eisai Pharmaceuticals
…
Market segment by Type, the product can be split into
Sodium Bicarbonates
N-Acetyl Cysteine
Statins
Others
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Renal Failure Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sodium Bicarbonates
1.4.3 N-Acetyl Cysteine
1.4.4 Statins
1.4.5 Others
1.5 Market by Application
1.5.1 Global Acute Renal Failure Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acute Renal Failure Therapeutics Market Perspective (2015-2026)
2.2 Global Acute Renal Failure Therapeutics Growth Trends by Regions
2.2.1 Acute Renal Failure Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Renal Failure Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Acute Renal Failure Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Renal Failure Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Renal Failure Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Renal Failure Therapeutics Players by Market Size
3.1.1 Global Top Acute Renal Failure Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Acute Renal Failure Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Renal Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Renal Failure Therapeutics Market Concentration Ratio
3.2.1 Global Acute Renal Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Renal Failure Therapeutics Revenue in 2019
3.3 Acute Renal Failure Therapeutics Key Players Head office and Area Served
3.4 Key Players Acute Renal Failure Therapeutics Product Solution and Service
3.5 Date of Enter into Acute Renal Failure Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acute Renal Failure Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Acute Renal Failure Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
5.2 Global Acute Renal Failure Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Renal Failure Therapeutics Market Size (2015-2020)
6.2 Acute Renal Failure Therapeutics Key Players in North America (2019-2020)
6.3 North America Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
6.4 North America Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Renal Failure Therapeutics Market Size (2015-2020)
7.2 Acute Renal Failure Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
7.4 Europe Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Acute Renal Failure Therapeutics Market Size (2015-2020)
8.2 Acute Renal Failure Therapeutics Key Players in China (2019-2020)
8.3 China Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
8.4 China Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Renal Failure Therapeutics Market Size (2015-2020)
9.2 Acute Renal Failure Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
9.4 Japan Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Renal Failure Therapeutics Market Size (2015-2020)
10.2 Acute Renal Failure Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Acute Renal Failure Therapeutics Market Size (2015-2020)
11.2 Acute Renal Failure Therapeutics Key Players in India (2019-2020)
11.3 India Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
11.4 India Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Renal Failure Therapeutics Market Size (2015-2020)
12.2 Acute Renal Failure Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Renal Failure Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Acute Renal Failure Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview
13.1.3 Baxter Acute Renal Failure Therapeutics Introduction
13.1.4 Baxter Revenue in Acute Renal Failure Therapeutics Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview
13.2.3 Teva Pharmaceutical Acute Renal Failure Therapeutics Introduction
13.2.4 Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Acute Renal Failure Therapeutics Introduction
13.3.4 Pfizer Revenue in Acute Renal Failure Therapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Acute Renal Failure Therapeutics Introduction
13.4.4 Novartis Revenue in Acute Renal Failure Therapeutics Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Eisai Pharmaceuticals
13.5.1 Eisai Pharmaceuticals Company Details
13.5.2 Eisai Pharmaceuticals Business Overview
13.5.3 Eisai Pharmaceuticals Acute Renal Failure Therapeutics Introduction
13.5.4 Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2015-2020)
13.5.5 Eisai Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acute Renal Failure Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Renal Failure Therapeutics Revenue
Table 3. Ranking of Global Top Acute Renal Failure Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sodium Bicarbonates
Table 6. Key Players of N-Acetyl Cysteine
Table 7. Key Players of Statins
Table 8. Key Players of Others
Table 9. Global Acute Renal Failure Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Acute Renal Failure Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Acute Renal Failure Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Acute Renal Failure Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Acute Renal Failure Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Acute Renal Failure Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Acute Renal Failure Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Acute Renal Failure Therapeutics Players
Table 20. Global Acute Renal Failure Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Acute Renal Failure Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Acute Renal Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Renal Failure Therapeutics as of 2019)
Table 23. Global Acute Renal Failure Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Renal Failure Therapeutics Product Solution and Service
Table 26. Date of Enter into Acute Renal Failure Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Acute Renal Failure Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Acute Renal Failure Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Acute Renal Failure Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Acute Renal Failure Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 36. North America Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 38. North America Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 42. Europe Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 48. China Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 50. China Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 54. Japan Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 66. India Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 68. India Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Acute Renal Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Acute Renal Failure Therapeutics Market Share (2019-2020)
Table 72. Central & South America Acute Renal Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Acute Renal Failure Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Acute Renal Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Acute Renal Failure Therapeutics Market Share by Application (2015-2020)
Table 76. Baxter Company Details
Table 77. Baxter Business Overview
Table 78. Baxter Product
Table 79. Baxter Revenue in Acute Renal Failure Therapeutics Business (2015-2020) (Million US$)
Table 80. Baxter Recent Development
Table 81. Teva Pharmaceutical Company Details
Table 82. Teva Pharmaceutical Business Overview
Table 83. Teva Pharmaceutical Product
Table 84. Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2015-2020) (Million US$)
Table 85. Teva Pharmaceutical Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Acute Renal Failure Therapeutics Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Acute Renal Failure Therapeutics Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Eisai Pharmaceuticals Company Details
Table 97. Eisai Pharmaceuticals Business Overview
Table 98. Eisai Pharmaceuticals Product
Table 99. Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2015-2020) (Million US$)
Table 100. Eisai Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Renal Failure Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Sodium Bicarbonates Features
Figure 3. N-Acetyl Cysteine Features
Figure 4. Statins Features
Figure 5. Others Features
Figure 6. Global Acute Renal Failure Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Acute Renal Failure Therapeutics Report Years Considered
Figure 11. Global Acute Renal Failure Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acute Renal Failure Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Acute Renal Failure Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acute Renal Failure Therapeutics Market Share by Players in 2019
Figure 16. Global Top Acute Renal Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Renal Failure Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acute Renal Failure Therapeutics Revenue in 2019
Figure 18. North America Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acute Renal Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
急性心不全（AHF）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026. Global Acute Heart Failure (AHF) Thera…- 急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 高度腎細胞癌治療薬の世界市場（～2026年） Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …
- 急性骨髄性白血病治療薬の世界市場（～2026年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- 急性冠症候群治療薬の世界市場（～2026年） ACS or Acute coronary syndrome refers to the set of conditions which occurs on account of decreasing flow of blood in coronary arteries owing to which the heart muscle is not able to function. There are various symptoms associated with this condition. The most commonly occurring symptom includes che…